427 related articles for article (PubMed ID: 10669643)
1. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
[TBL] [Abstract][Full Text] [Related]
2. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.
Brousseau ME; Santamarina-Fojo S; Vaisman BL; Applebaum-Bowden D; Bérard AM; Talley GD; Brewer HB; Hoeg JM
J Lipid Res; 1997 Dec; 38(12):2537-47. PubMed ID: 9458277
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
[TBL] [Abstract][Full Text] [Related]
5. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
6. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
7. Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.
Brousseau ME; Santamarina-Fojo S; Zech LA; Bérard AM; Vaisman BL; Meyn SM; Powell D; Brewer HB; Hoeg JM
J Clin Invest; 1996 Apr; 97(8):1844-51. PubMed ID: 8621767
[TBL] [Abstract][Full Text] [Related]
8. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
9. Transgenic rabbits as models for atherosclerosis research.
Brousseau ME; Hoeg JM
J Lipid Res; 1999 Mar; 40(3):365-75. PubMed ID: 10064724
[TBL] [Abstract][Full Text] [Related]
10. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
11. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
[TBL] [Abstract][Full Text] [Related]
12. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.
Chen Z; Chu D; Castro-Perez JM; Ni W; Zhang A; Krsmanovic ML; Xie D; Shah V; Stout SJ; McLaren DG; Stefanni AC; Lee SH; Roddy TP; Plump AS; Hubbard BK; Vogt TF; Zhou HH
J Cardiovasc Transl Res; 2011 Dec; 4(6):801-10. PubMed ID: 21822774
[TBL] [Abstract][Full Text] [Related]
13. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice.
Furbee JW; Francone O; Parks JS
J Lipid Res; 2002 Mar; 43(3):428-37. PubMed ID: 11893779
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
[TBL] [Abstract][Full Text] [Related]
15. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT.
Furbee JW; Francone O; Parks JS
J Lipid Res; 2001 Oct; 42(10):1626-35. PubMed ID: 11590219
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM; Withycombe S; Young SG
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1567-70. PubMed ID: 11597927
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
[TBL] [Abstract][Full Text] [Related]
18. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
19. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.
Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW
J Lipid Res; 2001 Feb; 42(2):201-10. PubMed ID: 11181749
[TBL] [Abstract][Full Text] [Related]
20. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
